POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION IN A TERTIARY CARE HOSPITAL OF NORTH EAST INDIA

MUKUNDAM BORAH; DWIPEN KHANIKAR; SHASHANKA SHEKHAR CHAKRABORTY; ANANGA CHARKRABORTY; DIPTIMAYEE DEVI; VIBHOR DUDHRAJ; ARTI BAHL

doi:10.22159/ijpps.2024v16i12.52442

Authors

MUKUNDAM BORAH Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India https://orcid.org/0009-0004-6092-7710
DWIPEN KHANIKAR Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India https://orcid.org/0000-0002-6648-1068
SHASHANKA SHEKHAR CHAKRABORTY Department of Community Medicine, Tezpur Medical College and Hospital, Tezpur- 784010, Assam, India https://orcid.org/0000-0001-7740-3607
ANANGA CHARKRABORTY Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India https://orcid.org/0009-0005-6162-4874
DIPTIMAYEE DEVI Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India
VIBHOR DUDHRAJ Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India https://orcid.org/0000-0001-9661-1030
ARTI BAHL Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India https://orcid.org/0000-0003-0123-8558

DOI:

https://doi.org/10.22159/ijpps.2024v16i12.52442

Keywords:

Point prevalence survey, antibiotic consumption, antimicrobial stewardship

Abstract

Objective: The study was conducted to quantify antimicrobial utilization and determine the patterns of antibiotic use in Indoor patients and ICUs of the hospital.

Methods: The Point Prevalent Survey (PPS) was conducted in a core “National Antimicrobial Consumption Network site” as a part of the National Centre for Disease Control - WHO project “Point prevalence survey of antimicrobial consumption at healthcare facilities.” The study was conducted as per the “WHO Methodology for PPS on Antibiotic use in hospitals” in March, 2022. Altogether, 1396 eligible patients were admitted during the survey period, and 1109 patients were included in the survey. Data were collected using a predesigned and pretested questionnaire in separate hospital, ward and patient forms.

Results: The prevalence of antibiotic use during the study was 79.44%. On an average, 1.39 antibiotics were in use per patient and only a minor fraction of (1.5%) patients received definitive therapy. Parenteral route of administration (92.72%) was mostly used for administration of antibiotics. The most common indication for antibiotic use was found to be surgical prophylaxis (30.66%). There were 154 antibiotic prescriptions in the 'Not Recommended' category. Double gram negative and double anaerobic cover accounted for 25% and 8.3% respectively of the total prescriptions.

Conclusion: Empirical use of antibiotics is common and lack of utilisation of antimicrobial susceptibility testing services requires urgent interventions. Routine monitoring of antibiotic use is recommended to improve the current scenario of antimicrobial consumption.

Downloads

Download data is not yet available.

References

Taneja N, Sharma M. Antimicrobial resistance in the environment: The Indian scenario. Indian J Med Res. 2019 Feb;149(2):119-128. doi: 10.4103/ijmr.IJMR_331_18. PMID: 31219076; PMCID: PMC6563737.

Shallcross LJ, Howard SJ, Fowler T, Davies SC. Tackling the threat of antimicrobial resistance: From policy to sustainable action. Philos Trans R Soc Lond B Biol Sci. 2015 Jun 5;370(1670):20140082. doi: 10.1098/rstb.2014.0082. PMID: 25918440; PMCID: PMC4424432.

Rice LB. Antimicrobial Stewardship and Antimicrobial Resistance. Med Clin North Am. 2018 Sep; 102(5):805-818. doi: 10.1016/j.mcna.2018.04.004. Epub 2018 Jul 14. PMID: 30126572.

Al-Omari A, Al Mutair A, Alhumaid S, Salih S, Alanazi A, Albarsan H, Abourayan M, Al Subaie M. The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: Results of a five-years pre-post analysis. Antimicrob Resist Infect Control. 2020 Jun 29;9(1):95. doi: 10.1186/s13756-020-00751-4. PMID: 32600391; PMCID: PMC7322716.

Karuniawati H, Yulianti T, Aini DK, Nurwienda FI. Impact of antimicrobial stewardship program on the use of antibiotics in pneumonia patients at teaching hospital in Surakarta Indonesia. International Journal of Applied Pharmaceutics 2021, 13(1), 20–23. Https://Doi.Org/10.22159/Ijap.2021.V13s1.Y0067

Pauwels I, Versporten A, Vermeulen H, Vlieghe E, Goossens H. Assessing the impact of the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) on hospital antimicrobial stewardship programmes: Results of a worldwide survey. Antimicrob Resist Infect Control. 2021 Sep 28;10(1):138. doi: 10.1186/s13756-021-01010-w. PMID: 34583775; PMCID: PMC8478001.

Ankrah D, Owusu H, Aggor A, Osei A, Ampomah A, Harrison M, Nelson F, Aboagye GO, Ekpale P, Laryea J, Selby J, Amoah S, Lartey L, Addison O, Bruce E, Mahungu J, Mirfenderesky M. Point Prevalence Survey of Antimicrobial Utilization in Ghana's Premier Hospital: Implications for Antimicrobial Stewardship. Antibiotics (Basel). 2021 Dec 14;10(12):1528. doi: 10.3390/antibiotics10121528. PMID: 34943740; PMCID: PMC8698913.

World Health Organization. WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals. 2019. Available: https://www.who.int/publications/i/item/WHO-EMP-IAU-2018.01.

Oo WT, Carr SD, Marchello CS, San MM, Oo AT, Oo KM, Lwin KT, Win HH, Crump JA. Point-prevalence surveys of antimicrobial consumption and resistance at a paediatric and an adult tertiary referral hospital in Yangon, Myanmar. Infect Prev Pract. 2021 Dec 11;4(1):100197. doi: 10.1016/j.infpip.2021.100197. PMID: 35005602; PMCID: PMC8717234.

Fentie AM, Degefaw Y, Asfaw G, Shewarega W, Woldearegay M, Abebe E, Gebretekle GB. Multicentre point-prevalence survey of antibiotic use and healthcare-associated infections in Ethiopian hospitals. BMJ Open. 2022 Feb 11;12(2):e054541. doi: 10.1136/bmjopen-2021-054541. PMID: 35149567; PMCID: PMC8845215.

Elhajji FD, Al-Taani GM, Anani L, Al-Masri S, Abdalaziz H, Qabba'h SH, Al Bawab AQ, Scott M, Farren D, Gilmore F, Versporten A, Goossens H, Aldeyab MA. Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan. BMC Health Serv Res. 2018;18(1):849. doi: 10.1186/s12913-018-3656-y. PMID: 30419895; PMCID: PMC6233602.

WHO. World Health Organizaton collaborating centre for drug statistics methodology, ATC/DDD index 2023. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2013.https://www.whocc.no/atc_ddd_index/

WHO. The 2021 WHO aware classification of antibiotics for evaluation and monitoring of use. World Health Organization 2021. Available:https://www.who.int/publications/i/item/2021-aware-classification

Sheikh S, Vishwas G, Aggarwal M, Bhattacharya S, Kumari P, Parashar L, Meshram GG. Antibiotic point prevalence survey at a tertiary healthcare hospital in India: Identifying strategies to improve the antibiotic stewardship program immediately after a COVID-19 wave. Infect Prev Pract. 2022 Dec;4(4):100253. doi: 10.1016/j.infpip.2022.100253. Epub 2022 Oct 14. PMID: 36276168; PMCID: PMC9562613.

Fazaludeen Koya S, Ganesh S, Selvaraj S, Wirtz VJ, Galea S, Rockers PC. Antibiotic consumption in India: Geographical variations and temporal changes between 2011 and 2019. JAC Antimicrob Resist. 2022 Oct 26;4(5):dlac112. doi: 10.1093/jacamr/dlac112. PMID: 36320447; PMCID: PMC9596537.

Haque M. Antimicrobial use, prescribing, and resistance in selected ten selected developing countries: A brief overview. Asian J Pharm Clin Res 2017;10(8):37-45.

Panditrao AM, Shafiq N, Chatterjee S, Pathak A, Trivedi N, Sadasivam B, Kshirsagar N, Kaul R, Biswal M, Kakkar A, Malhotra S, Arora P, Talati S, Dhaliwal N, Hazra A, Jhaj R, Najmi A, Pandey N, Chakraverty R, Pathan S, Chauhan J, Mathur A; ASPIRE (‘Antimicrobial Stewardship Programme In Resource-limited Environment’) Study Group. A multicentre point prevalence survey (PPS) of antimicrobial use amongst admitted patients in tertiary care centres in India. J Antimicrob Chemother. 2021 Mar 12;76(4):1094-1101. doi: 10.1093/jac/dkaa533. PMID: 34244744.

Ogunleye OO, Oyawole MR, Odunuga PT, Kalejaye F, Yinka-Ogunleye AF, Olalekan A, Ogundele SO, Ebruke BE, Kalada Richard A, Anand Paramadhas BD, Kurdi A, Sneddon J, Seaton A, Godman B. A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: Findings and implications. Expert Rev Anti Infect Ther. 2022 Feb;20(2):297-306. doi: 10.1080/14787210.2021.1941870. Epub 2021 Jun 21. PMID: 34128756.

Saleem Z, Hassali MA, Versporten A, Godman B, Hashmi FK, Goossens H, Saleem F. A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications. Expert Rev Anti Infect Ther. 2019 Apr;17(4):285-293. doi: 10.1080/14787210.2019.1581063. Epub 2019 Feb 22. PMID: 30755077.

Kumar S, Shukla P, Goel P, Mishra V, Gupta A, Karuna T, Srivastava R, Gupta A, Baharani D, Pansey P, Chandiwal S, Shrivastava S, Gupta A, Rajpoot SS, Biswal D, Ansari M, Walia K, Khadanga S. Point Prevalence Study (PPS) of antibiotic usage and Bacterial culture rate (BCR) among secondary care hospitals of small cities in central India: Consolidating Indian evidence. J Lab Physicians. 2023 Feb 9;15(2):259-263. doi: 10.1055/s-0042-1757585. PMID: 37323604; PMCID: PMC10264115.

Singh SK, Sengupta S, Antony R, Bhattacharya S, Mukhopadhyay C, Ramasubramanian V, Sharma A, Sahu S, Nirkhiwale S, Gupta S, Rohit A, Sharma S, Raghavan V, Barman P, Sood S, Mamtora D, Rengaswamy S, Arora A, Goossens H, Versporten A. Variations in antibiotic use across India: Multi-centre study through Global Point Prevalence survey. J Hosp Infect. 2019 Nov;103(3):280-283. doi: 10.1016/j.jhin.2019.05.014. Epub 2019 Jun 3. PMID: 31170422.

Dhole S, Mahakalkar C, Kshirsagar S, Bhargava A. Antibiotic prophylaxis in surgery: Current insights and future directions for surgical site infection prevention. Cureus. 2023 Oct 28;15(10):e47858. doi: 10.7759/cureus.47858. PMID: 38021553; PMCID: PMC10680052.

Global Guidelines for the Prevention of Surgical Site Infection. Geneva: World Health Organization; 2018. Web Appendix 25, Summary of a systematic review on surgical antibiotic prophylaxis prolongation. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536429/

Anugulruengkitt S, Charoenpong L, Kulthanmanusorn A, Thienthong V, Usayaporn S, Kaewkhankhaeng W, Rueangna O, Sophonphan J, Moolasart V, Manosuthi W, Tangcharoensathien V. Point prevalence survey of antibiotic use among hospitalized patients across 41 hospitals in Thailand. JAC Antimicrob Resist. 2023 Jan 4;5(1):dlac140. doi: 10.1093/jacamr/dlac140. PMID: 36628340; PMCID: PMC9825250

Lovena Preeyadarshini VM, Harena RA, Mohammad II, Eric C. Point prevalence survey on antibiotic use in the hospitals of Mauritius. Frontiers in Antibiotics. 2023 (1):1-9. https://doi.org/10.3389/frabi.2022.1045081

Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014 Dec;5(6):229-41. doi: 10.1177/2042098614554919. PMID: 25436105; PMCID: PMC42325